Implementing New Diabetic Kidney Disease Treatments – Time to Act 4 links

• Recording
• Agenda
• Slides
• Bios

Implementing New Diabetic Kidney Disease Treatments – Time to Act 3 links

• Recording
• Slides
• Bios

Implementing New Diabetic Kidney Disease Treatments – Time for Nephrologists to Act 2 links

• Agenda
• Slides

Centers for Disease Control and Prevention (CDC) Resources 5 links

• CDC Monkeypox Guidance
• Clinical Considerations for Monkeypox in People Who are Pregnant or Breastfeeding
• Clinical Considerations for Monkeypox in Children and Adolescents
• Letter from Director of the CDC (07.27.22)
• Monkeypox 101: What Clinicians Need to Know (07.22.22)

Frequently Asked Questions About Monkeypox for the Dialysis Setting 1 link

• FAQ Document

General DKD Information 10 links

• Diabetic Kidney Disease: Challenges, Progress, and Possibilities
• The Global Epidemiology of Diabetes and Kidney Disease
• Chronic Kidney Disease Testing Among At-Risk Adults in the U.S. Remains Low: Real-World Evidence From a National Laboratory Database
• KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease
• Preserving Kidney Function Instead of Replacing It
• Implications of Specialist Density for Diabetes Care in the United States
• Cardio-Renal-Metabolic Care Models Toward Achieving Effective Interdisciplinary Care
• Overcoming Barriers to Implementing New Therapies for Diabetic Kidney Disease: Lessons Learned
• Health Care Access and Use Among Adults with Diabetes During the COVID-19 Pandemic — United States, February–March 2021
• Submaximal Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Dosing Among Persons With Proteinuria

Complications of DKD 4 links

• Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2021
• Global trends in diabetes complications: A review of current evidence
• Changes in Diabetes-Related Complications in the United States, 1990–2010
• Relative Incidence of ESRD Versus Cardiovascular Mortality in Proteinuric Type 2 Diabetes and Nephropathy: Results From the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) Database

Outcomes and Data Associated with DKD 9 links

• Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group: KDIGO 2020 clinical practice guideline for diabetes management in chronic kidney disease
• Centers for Disease Control and Prevention: National Diabetes Statistics Report
• International Diabetes Federation: IDF Diabetes Atlas, 9th Ed
• Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016
• Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013
• Heart Disease and Stroke Statistics—2021 Update
• Clinical Characteristics of and Risk Factors for Chronic Kidney Disease Among Adults and Children An Analysis of the CURE-CKD Registry
• Vital Signs: Decrease in Incidence of Diabetes-Related End-Stage Renal Disease among American Indians/Alaska Natives — United States, 1996–2013
• Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: A systematic review and meta-analysis of randomised trials.

Medications Associated with DKD 17 links

• Submaximal Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Dosing Among Persons With Proteinuria
• Trends in Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use among Those with Impaired Kidney Function in the United States
• Canagliflozin and renal outcomes in type 2 diabetes and nephropathy
• Dapagliflozin in Patients with Chronic Kidney Disease
• Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
• Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes
• Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes
• Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
• Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): A multicentre, open-label, randomised trial
• Prescribing Trends of Antidiabetes Medications in Patients With Type 2 Diabetes and Diabetic Kidney Disease: A Cohort Study
• Sodium Glucose Cotransporter 2 Inhibition Heralds a Call-to-Action for Diabetic Kidney Disease
• Cost-Effectiveness of Empagliflozin in Patients With Diabetic Kidney Disease in the United States: Findings Based on the EMPA-REG OUTCOME Trial
• Assessing the cost-effectiveness of sodium-glucose cotransporter-2 inhibitors in type 2 diabetes mellitus: A comprehensive economic evaluation using clinical trial and real-world evidence
• Cost-effectiveness of empagliflozin in patients with diabetic kidney disease in the United States: Findings based on the EMPA-REG OUTCOME Trial
• The Medical Letter: Comparison Chart: Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors
• In the Years Before the COVID-19 Pandemic, Nearly 13 Million Adults Delayed or Did Not Get Needed Prescription Drugs Because of Costs
• Sodium-glucose co-transporter inhibitors, their role in type 1 diabetes treatment and a risk mitigation strategy for preventing diabetic ketoacidosis: The STOP DKA Protocol

DKD and the Pediatric Population 2 links

• Trends in Prevalence of Type 1 and Type 2 Diabetes in Children and Adolescents in the US, 2001-2017
• Prevalence of Hypertension and Albuminuria in Pediatric Type 2 Diabetes: A Systematic Review and Meta-analysis

DKD Payment and Drug Pricing 3 links

• RAND Health Care: Value-Based Payment and Health Care System Preparedness and Resilience
• Framework For Specialty Value Transformation: Perspectives From A Commercial Payer
• Contributor: A More Nuanced View of Dialysis Providers “Gaming the Rules”

DKD and Diversity/Equality 6 links

• Reported Racial Discrimination, Trust in Physicians, and Medication Adherence Among Inner-City African Americans With Hypertension
• Beyond Consent: Building Trusting Relationships with Diverse Populations in Precision Medicine Research
• Effects of Community-Based Health Worker Interventions to Improve Chronic Disease Management and Care Among Vulnerable Populations: A Systematic Review
• A Unifying Approach for GFR Estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease
• New Creatinine- and Cystatin C–Based Equations to Estimate GFR without Race
• Time to Eliminate Health Care Disparities in the Estimation of Kidney Function

Management of Diabetes & Kidney Disease through COVID-19 4 links

• Recording
• Slides
• Bios
• Why Should I Join A Clinical Trail?

Goal-Directed Medical Therapies (GDMT) for Patients with Diabetic Kidney Disease and Beyond 3 links

• Recording
• Slides
• Bios

New Approaches to Transform Outcomes for Kidney Disease and Heart Disease in Patients with Diabetes 3 links

• Recording
• Slides
• Bios

Clostridioides difficile (C-diff or CDI) 2 links

• Suggestions for the prevention of Clostridioides difficile spread within outpatient hemodialysis facilities
• Clostridioides difficile Infection Among Patients Requiring Maintenance Hemodialysis

Ebola 7 links

• Ebola Gap Analysis
• Ebola: Responding to a Growing Crisis (webinar)
• ASPR TRACIE: Healthcare System Readiness for Highly Pathogenic Infectious Diseases
• National Emerging Special Pathogens Training and Education
• World Health Organization (WHO): Ebola Virus Disease
• ASPR TRACIE: Highly Pathogenic Infectious Disease Exercise Planning for Front Line Facilities
• U.S. Department of Health & Human Services Topic Collection: VHF/Ebola

Hepatitis A 3 links

• Widespread person-to-person outbreaks of hepatitis A across the United States
• HAV Vaccination Guidance During the COVID-19 Pandemic
• Hepatitis A Information from the CDC

Hepatitis B 2 links

• ACIP Recommendations
• VIS - Hepatitis B Vaccine

Hepatitis C 4 links

• KDIGO Guidelines "Hepatitis C in CKD" (2018)
• KDIGO 2018 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease
• CDC/NTDS Hepatitis C Testing and Monitoring Algorithm
• AJKDBlog: Caring for Patients with Hepatitis C and CKD in the Modern Era: The 2018 KDIGO Guideline

Emergency Management in Dialysis 8 links

• CDC Health Alert Network (HAN)
• Dialysis Care After a Disaster
• Guidance for Reopening Healthcare Facilities After Water and Wind Damage
• Guideline for Disinfection and Sterilization in Healthcare Facilities
• Guidelines for Environmental Infection Control in Health-Care Facilities
• Infection Prevention for Ambulatory Care Centers During Disasters
• Natural Disasters and Severe Weather: Infection Control
• Guidance for Healthcare Water System Repair and Recovery Following a Boil Water Alert or Disruption of Water Supply

Asbestos Risks in Disasters 3 links

• Asbestos and Natural Disasters Guide
• Emergency Plan for a Natural Disaster
• Mesothelioma Symptoms

Water Supply After a Disaster 3 links

• Technical Considerations When Bringing Hemodialysis Facilities' Water Systems Back on Line After a Disaster
• Considerations for Reducing Risk: Water in Healthcare Facilities
• Emergency Water Supply Planning Guide for Hospitals and Healthcare Facilities

CDC 8 links

• Core Infection Prevention and Control Practices for Safe Healthcare Delivery in All Settings
• Dialysis Safety: Core Interventions
• Dialysis Safety Index
• Dialysis: Reducing Infections and Changing Culture (podcast)
• Discussion of Respiratory Protection Recommendations for Measles, Varicella, and Disseminated Zoster
• Infection Control in Healthcare Personnel
• Making Dialysis Safer for Patients: Tools to Prevent Infections in Hemodialysis (video)
• Transmission-Based Precautions

CMS 2 links

• ESRD Quality Incentive Program
• Interpretive Guidance of the ESRD Conditions for Coverage for Dialysis Facilities (304 pages)

Environmental Cleaning and Disinfection 3 links

• Environmental Surface Disinfection in Dialysis Facilities: Notes for Clinical Managers
• Checklist: Dialysis Station Routine Disinfection
• Core Strategies of Environmental Cleaning and Disinfection in Hospitals

National Healthcare Safety Network (NHSN) 1 link

• NHSN Tracking Infections in Outpatient Dialysis Facilities

Publications 6 links

• Essential Components of an Infection Prevention Program for Outpatient Hemodialysis Centers
• 100% Use of Infection Control Procedures in Hemodialysis Facilities: Call to Action
• Evolving Role of the Medical Director of a Dialysis Facility
• Infection control guidelines in hemodialysis facilities
• Leading the Dialysis Unit: Role of the Medical Director
• Maintaining Safety in the Dialysis Facility

Safe Injection Practices 4 links

• CDC Injection Safety
• Hemodialysis Injectable Medication Preparation Audit Tool
• Medication Safety Principles and Practice in CKD
• Safe Injection Practices - How to Do It Right (video)

Water Safety in Dialysis 3 links

• ANSI/AAMI/ISO 23500-5:2019; Preparation and quality management of fluids for haemodialysis and related therapies—Part 5: Quality of dialysis fluid for haemodialysis and related therapies
• Water Use in Hemodialysis
• What Medical Directors Need to Know about Dialysis Facility Water Management

Vascular Access Infections 6 links

• Prevention of Bloodstream Infections in Patients Undergoing Hemodialysis
• CDC Approach to BSI Prevention in Dialysis Facilities (i.e., the Core Interventions)
• Catheter-related blood stream infections in hemodialysis patients: a prospective cohort study
• Dialysis BSI Prevention Collaborative
• NHSN Tracking Infections in Outpatient Dialysis Facilities
• CDC Dialysis Safety: Core Interventions

Blood Culture Collection 1 link

• Standardization of Blood Culture Collection for Patients Receiving In-Center Hemodialysis

Past Webinars 7 links

• Saving Lives and Saving Money: AI for Improvement in AKI (recorded June 7, 2022)
• ASN COVID-19 Roundtable: Outpatient Therapeutics Webinar (recorded February 11, 2022)
• Management of Clostridioides difficile Infections in Outpatient Hemodialysis Settings (recorded Friday, September 24, 2021)
• Use of Monoclonal Antibodies for the Treatment of Mild to Moderate SARS-COV-2 in Patients Receiving Hemodialysis: A Kidney Community Conversation (recorded March 11, 2021)
• New Approaches to Transform Outcomes for Kidney Disease and Heart Disease in Patients with Diabetes (recorded Thursday, December 10, 2020)
• Goal-Directed Medical Therapies for Patients with Diabetic Kidney Disease (recorded Tuesday, September 29, 2020)
• Management of Diabetes & Kidney Disease through COVID-19 (recorded Tuesday, August 18, 2020)

From ASN eLearning Center 6 links

• NTDS Targeting Zero Infections Webinar Series: Human Factors Engineering and its Application to Dialysis (recorded Tuesday, September 17, 2019)
• Targeting Zero Infections: Hepatitis C Detection, Prevention, and Treatment (recorded Thursday, December 6, 2018)
• Targeting Zero Infections: Environmental Decontamination (recorded Tuesday, June 19, 2018)
• Targeting Zero Infections: Infectious Disease Reporting: State Requirements & Resources (recorded Thursday, March 29, 2018)
• Targeting Zero Infections: MDROs and Antimicrobial Stewardship in the Dialysis Facility (recorded Wednesday, September 27, 2017)
• Targeting Zero Infections: Where Do We Begin? (recorded Tuesday, May 23, 2017)

Recommendations 2 links

• ACIP Recommendations
• VIS - Recombinant Zoster (Shingles)

Recommendations 6 links

• NEW Age Recommendations for Pneumococcal Vaccination
• ACIP Recommendations
• PneumoRecs VaxAdvisor App for Vaccine Providers
• Pneumococcal Vaccine Reccomendations
• VIS - Pneumococcal Conjugate Vaccine
• VIS - Pneumococcal Polysaccharide Vaccine (PPSV23)

Articles 2 links

• American Journal of Kidney Diseases: “Mortality of Dialysis Patients According to Influenza and Pneumococcal Vaccination Status”
• American Journal of Kidney Diseases: “Influenza and Pneumococcal Vaccination in Dialysis Patients: Merely a Shot in the Arm?

Recomendations 8 links

• ACIP Recomendations
• Flu & People with Chronic Kidney Disease
• Information for the 2023-2024 Flu Season
• Prevention Strategies for Seasonal Influenza in Healthcare Settings | CDC
• Seasonal Influenza Vaccination Resources for Health Professionals
• VIS – Influenza Vaccine (Inactivated or Recombinant)
• Who Needs a Flu Vaccine?
• Vaccine Information Statement: Inactivated Influenza Vaccine

Articles 4 links

• American Journal of Kidney Diseases: “Mortality of Dialysis Patients According to Influenza and Pneumococcal Vaccination Status”
• American Journal of Kidney Diseases: “Influenza and Pneumococcal Vaccination in Dialysis Patients: Merely a Shot in the Arm?
• Clinical Journal of the American Society of Nephrology: “High-Dose Seasonal Influenza Vaccine in Patients Undergoing Dialysis”
• Journal of the American Society of Nephrology: “Racial and Ethnic Disparities in Seasonal Influenza Vaccination among Dialysis Facilities in the United States”

Recommendations 3 links

• NEW Recommendations for 2024-25
• ACIP Recommendations
• COVID-19 Vaccines for people who are moderately or severely immunocompromised

ASN Resources 4 links

• ASN COVID-19 Toolkit for Nephrology Clinicians: Preparing for the Surge
• ASN CDC Vaccine Poster – English
• ASN CDC Vaccine Poster – Spanish
• ASN CDC Vaccine Poster – Arabic

Articles 8 links

• Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing COVID-19–Related Thromboembolic Events
• SARS-CoV-2 Vaccination and Severe COVID-19 Infection and Reinfection Outcomes among Patients with ESKD
• Low circulation of antibodies correlates with risk for COVID-19 among patients on dialysis
• Navigating the Evolving Landscape ofCOVID-19: Strategies to IncreaseVaccine Confidence and ImproveVaccination Rates in the United States
• Kidney360: Oral Agents and SARS-CoV-2 Vaccine Effectiveness against Severe COVID-19 Omicron Events in Patients Requiring Maintenance Dialysis
• American Journal of Kidney Diseases: SARS-CoV-2 Vaccine Effectiveness and Breakthrough Infections Among Patients Receiving Maintenance Dialysis
• Journal of the American Society of Nephrology: “SARS-CoV-2 Vaccine Acceptability in Patients on Hemodialysis: A Nationwide Survey”
• Journal of the American Society of Nephrology: “Collaboration between Dialysis Providers and the American Society of Nephrology: Dialysis in the COVID Pandemic”

COVID-19 Therapy/Medications 2 links

• Find COVID-19 Medications
• COVID-19 Drug Interactions Checker

For Professionals 7 links

• Protect Yourself and Others from COVID-19, Flu, and RSV
• Healthcare Provider Toolkit: Preparing Your Patients for the Fall and Winter Virus Season
• Resources to Prepare for Flu, COVID-19, and RSV
• Sample Vaccination Policy Statement
• Clinical Outreach and Community Activity (COCA) Calls/Webinars
• Immunization Action Coalition
• 2021 Chronic Health Conditions Surveys - Gap– Between Healthcare Professionals and Adult Patients

For Patients 1 link

• Adult Vaccine Quiz / Tool (CDC) – Interactive

Standards 5 links

• CDC Standards for Adult Immunization Practice (SAIP)
• Vaccine Assessment
• Vaccine Recommendation
• Vaccine Administration and Referral
• Documentation

Administration 2 links

• Vaccine Administration Pinkbook
• Vaccine Adverse Event Reporting System (VAERS)

Schedules 8 links

• CDC Adult Immunization Schedule
• CDC Stay Up-to-Date With Your Vaccines
• CDC What Vaccines Are Recommend for You
• CDC Extra Precautions – People with Medical Conditions
• Vaccine Recommendations and Guidance of the ACIP – List of Errata/Updates
• Renal Disease and Adult Vaccination
• Recommended Adult Immunization Schedule by Medical Condition
• Recommended Adult Immunization Schedule for ages 19 or older